Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 15 January 2026

CrowdStrike (CRWD) stock rises after judge tosses outage lawsuit, Seraphic deal in focus

CrowdStrike (CRWD) stock rises after judge tosses outage lawsuit, Seraphic deal in focus

CrowdStrike shares rose 1.2% to $466.07 after a U.S. judge dismissed a shareholder fraud lawsuit linked to its July 2024 outage. The court found investors failed to show executives made false statements or intended fraud. CrowdStrike is also expanding into browser and identity security through new acquisitions. Investors are watching for updates on deal closings and upcoming earnings.
15 January 2026
··
Netflix stock ticks up as Delaware judge blocks Paramount fast-track in Warner deal fight

Netflix stock ticks up as Delaware judge blocks Paramount fast-track in Warner deal fight

Netflix shares rose 0.6% to $89.08 after a Delaware judge denied Paramount Skydance’s request to fast-track its lawsuit over Warner Bros Discovery’s deal process. The prospect of an all-cash Netflix bid for Warner’s studios and streaming assets resurfaced. Investors await Netflix’s Jan. 20 earnings report for updates on the potential acquisition. Warner Bros Discovery and Paramount Skydance shares slipped midday.
15 January 2026
···
Pfizer stock dips as U.S. vaccine policy fight rattles demand outlook

Pfizer stock dips as U.S. vaccine policy fight rattles demand outlook

Pfizer shares fell 0.6% to $25.42 in late-morning trading Thursday as U.S. vaccine policy changes fueled uncertainty. Sanofi warned of weaker U.S. vaccine demand; Pfizer’s CEO criticized the new recommendations. Moderna and Merck also traded lower. Investors await Pfizer’s Feb. 3 results for updates on 2026 outlook and new product pipeline.
15 January 2026
········
Accenture stock steadies near $289 as Wells Fargo raises target; traders eye March 19 earnings call

Accenture stock steadies near $289 as Wells Fargo raises target; traders eye March 19 earnings call

Accenture shares rose 0.1% to $288.87 midday Thursday, holding gains after a 4.2% jump Wednesday. Wells Fargo raised its price target to $275 but maintained an equal-weight rating. Infosys’ revenue forecast upgrade boosted sentiment across IT services stocks. Accenture recently reported $18.74 billion in quarterly revenue, beating estimates, and announced an acquisition of UK AI firm Faculty.
15 January 2026
··
Home Depot stock nudges higher after Morgan Stanley lifts target as housing signals loom

Home Depot stock nudges higher after Morgan Stanley lifts target as housing signals loom

Home Depot shares rose 0.5% to $377.75 midday Thursday after Morgan Stanley raised its price target to $412. U.S. retail sales at building material stores climbed 1.3% in November, while weekly jobless claims fell to 198,000. Wall Street indexes rebounded, led by chip stocks and banks. Home Depot projects flat to 2% same-store sales growth for fiscal 2026.
15 January 2026
··
UnitedHealth stock rebounds as rural Medicare payment pilot rolls out, earnings next in focus

UnitedHealth stock rebounds as rural Medicare payment pilot rolls out, earnings next in focus

UnitedHealth shares rose 0.7% to $337.27 after rebounding from a 2% drop Thursday. The move followed UnitedHealthcare’s launch of a six-month pilot to speed Medicare Advantage payments for rural hospitals in four states. Investors are focused on the company’s Jan. 27 earnings and 2026 outlook. Rural providers face financial strains as federal budget changes loom.
15 January 2026
··
Boeing stock rises on Bernstein target hike as Delta’s Dreamliner deal keeps focus on deliveries

Boeing stock rises on Bernstein target hike as Delta’s Dreamliner deal keeps focus on deliveries

Boeing shares rose 1.6% to $246.40 by midday Thursday after Bernstein raised its price target to $298. Delta ordered 30 Boeing 787-10 jets, with options for 30 more. Boeing delivered 600 jets in 2025, its highest since 2018, and net orders surpassed Airbus for the first time in seven years. Investors await Boeing’s Jan. 27 earnings for updates on cash flow and 2026 outlook.
15 January 2026
··
Petrobras stock (PBR) slips as oil falls; Tupi hits 1 million bpd, fertilizer restart in focus

Petrobras stock (PBR) slips as oil falls; Tupi hits 1 million bpd, fertilizer restart in focus

Petrobras’ U.S.-listed shares fell 1.1% to $12.52 Thursday as energy stocks slipped with Brent crude down 3.3%. CEO Magda Chambriard said Petrobras hit 1 million bpd at the Tupi field and resumed ammonia and urea output at its Sergipe plant, with Bahia’s plant to follow by month’s end. The company’s 2026 annual meeting is set for April 16. Investors await 2025 results on March 5.
15 January 2026
··
Applied Materials stock jumps today as TSMC lifts 2026 capex and Barclays upgrades AMAT

Applied Materials stock jumps today as TSMC lifts 2026 capex and Barclays upgrades AMAT

Applied Materials surged 7.8% to $325.41 Thursday after TSMC raised its 2026 capital spending outlook to up to $56 billion, far above forecasts. Barclays upgraded Applied to “overweight” and Stifel raised its price target, citing stronger chip equipment demand. U.S. chip tool stocks rallied broadly. Applied warned that tighter U.S. export rules could cut $600 million from 2026 revenue.
15 January 2026
··
Why Eli Lilly stock is down today: FDA pushes obesity pill decision to April 10

Why Eli Lilly stock is down today: FDA pushes obesity pill decision to April 10

Eli Lilly shares fell 4.7% to $1,022.50 after Reuters reported the FDA delayed its decision on the company’s experimental weight-loss pill to April 10. Strive Specialties sued Lilly and Novo Nordisk in Texas, alleging anticompetitive practices tied to GLP-1 drugs. Novo Nordisk shares dropped 3.6%. Investors await Lilly’s Feb. 4 earnings for updates on the pill’s timeline and legal risks.
15 January 2026
·
Rivian stock slips again as UBS turns bearish — Wall Street tests the R2 and autonomy story

Rivian stock slips again as UBS turns bearish — Wall Street tests the R2 and autonomy story

Rivian shares slipped 1.1% to $17.32 Thursday morning after analyst downgrades from Wolfe Research and UBS, which cited concerns over autonomy timelines and valuation. The stock has fallen 7.2% since Wednesday’s close. Rivian named Greg Revelle chief customer officer ahead of the R2 SUV launch, with first deliveries expected in the first half of 2026. Fourth-quarter and full-year results are due Feb. 12.
15 January 2026
··
IREN stock slips as broker trims forecasts but keeps $80 target

IREN stock slips as broker trims forecasts but keeps $80 target

IREN shares fell 0.5% to $52.61 Thursday after H.C. Wainwright cut near-term earnings forecasts but kept a Buy rating and $80 target. Bitcoin dropped 0.8%, pressuring crypto-linked stocks. IREN’s AI push includes a $9.7 billion Microsoft deal and a $5.8 billion Dell supply agreement, both tied to GPU data center expansion in Texas. Delays in execution could trigger penalties, according to recent filings.
15 January 2026
·
1 … 324 325 326 327 328 … 1,170

Stock Market Today

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
ASML stock price snaps back as AI spending bets return, with ex-dividend date next

ASML stock price snaps back as AI spending bets return, with ex-dividend date next

7 February 2026
ASML shares rose 3.84% Friday in Amsterdam to 1,193.80 euros, rebounding with global chip stocks after Amazon signaled a sharp increase in AI-related capital spending. The stock goes ex-dividend Feb. 9 ahead of a 1.60-euro interim payout. ASML’s Nasdaq shares climbed 4.64% to $1,413.01. Despite Friday’s gains, the Amsterdam listing finished the week about 2.5% lower.
Go toTop